Literature DB >> 29188814

Vascular disease: PCSK9 inhibition in PAD.

Karina Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29188814     DOI： 10.1038/nrcardio.2017.204

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

Authors:  Marc P Bonaca; Patrice Nault; Robert P Giugliano; Anthony C Keech; Armando Lira Pineda; Estella Kanevsky; Julia Kuder; Sabina A Murphy; J Wouter Jukema; Basil S Lewis; Lale Tokgozoglu; Ransi Somaratne; Peter S Sever; Terje R Pedersen; Marc S Sabatine
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690
  1 in total
  1 in total

1.  Proteomic Profiling of Cryoglobulinemia.

Authors:  Peng Liu; Jianqiang Wu; Dandan Sun; Haolong Li; Zhihong Qi; Xiaoyue Tang; Wei Su; Yongzhe Li; Xuzhen Qin
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.